Ionis Pharmaceuticals (IONS) Reports Pfizer (PFE) to Begin Phase 2b Clinical Study of Vupanorsen (AKCEA-ANGPTL3-LRx)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. UNFI
8. SPY
9. ASO
10. DYN

Go back to Ionis Pharmaceuticals (IONS) Reports Pfizer (PFE) to Begin Phase 2b Clinical Study of Vupanorsen (AKCEA-ANGPTL3-LRx)
(NASDAQ: IONS) Delayed: 56.71 --0 (-0%)
Previous Close $56.71    52 Week High $62.68 
Open $56.71    52 Week Low $19.59 
Day High $56.71    P/E N/A 
Day Low $56.71    EPS $0.00 
Volume 4,963       

Pfizer Inc. (NYSE: PFE) Delayed: 27.79 --0 (-0%)
Previous Close $27.79    52 Week High $37.39 
Open $27.79    52 Week Low $28.25 
Day High $27.79    P/E 16.84 
Day Low $27.79    EPS $1.65 
Volume 296,238